Integrated intelligence for precision therapy

Transforming patient lives through pioneering research connecting the body’s neural networks and bioelectronic devices to stimulate healthy patterns and treat disease. Examples of our research targets include obesity, diabetes, thyroid dysfunction, cancers, stroke, and depression.

News

Carnegie Mellon lands ARPA-H award for implantable bioelectric medicine project Opens in new window

A CMU-led project team secured an award of up to $42M from ARPA-H to accelerate the development of implantable bioelectronic devices that deliver patient-specific therapy and monitor disease status.

CMU-led project to fight obesity, Type 2 diabetes receives ARPA-H backing Opens in new window

A CMU-led team of researchers has secured an award of up to $34.9 million from ARPA-H to develop a new bioelectric medicine-based treatment for obesity and Type 2 diabetes patients.

CMU, Meta seek to make computer-based tasks accessible with wristband technology Opens in new window

In collaboration with Meta, Doug Weber’s lab is exploring how sEMG signals can enable people with spinal cord injuries to interact with computer and mixed reality systems.

Boosting oxygenation for transplanted cell-based therapies Opens in new window

To advance cell-based therapies, researchers have identified a novel device that makes on-site oxygen for biological cells transplanted inside the body.

Detecting brain tsunamis Opens in new window

Researchers from Carnegie Mellon University, the University of Pittsburgh, and the University of Cincinnati have combined their expertise in engineering and medicine to create a noninvasive method for detecting worsening brain injuries before they happen. This advancement could reshape neurocritical care.

ARPA-H fast tracks development of new cancer implant tech Opens in new window

ARPA-H has awarded $45 million to a multi-institutional team of researchers to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths.

New hope for people living with paralysis after stroke Opens in new window

Spinal cord stimulation technology developed by Douglas Weber in collaboration with the University of Pittsburgh offers new hope for people living with impairments that would otherwise be considered permanent.

Better than a hole in the head Opens in new window

Intracranial pressure sensing is the burgeoning focus of Jana Kainerstorfer’s biomedical optics lab, and her team is working to create noninvasive ICP sensing alternatives.